These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12393801)

  • 21. Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease.
    Howarth JL; Kelly S; Keasey MP; Glover CP; Lee YB; Mitrophanous K; Chapple JP; Gallo JM; Cheetham ME; Uney JB
    Mol Ther; 2007 Jun; 15(6):1100-5. PubMed ID: 17426712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy.
    Scaramuzzino C; Casci I; Parodi S; Lievens PMJ; Polanco MJ; Milioto C; Chivet M; Monaghan J; Mishra A; Badders N; Aggarwal T; Grunseich C; Sambataro F; Basso M; Fackelmayer FO; Taylor JP; Pandey UB; Pennuto M
    Neuron; 2015 Jan; 85(1):88-100. PubMed ID: 25569348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract.
    Minamiyama M; Katsuno M; Adachi H; Doi H; Kondo N; Iida M; Ishigaki S; Fujioka Y; Matsumoto S; Miyazaki Y; Tanaka F; Kurihara H; Sobue G
    Nat Med; 2012 Oct; 18(10):1531-8. PubMed ID: 23023499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
    Pandey UB; Nie Z; Batlevi Y; McCray BA; Ritson GP; Nedelsky NB; Schwartz SL; DiProspero NA; Knight MA; Schuldiner O; Padmanabhan R; Hild M; Berry DL; Garza D; Hubbert CC; Yao TP; Baehrecke EH; Taylor JP
    Nature; 2007 Jun; 447(7146):859-63. PubMed ID: 17568747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation.
    Mukherjee S; Thomas M; Dadgar N; Lieberman AP; Iñiguez-Lluhí JA
    J Biol Chem; 2009 Aug; 284(32):21296-306. PubMed ID: 19497852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease.
    Chua JP; Reddy SL; Yu Z; Giorgetti E; Montie HL; Mukherjee S; Higgins J; McEachin RC; Robins DM; Merry DE; Iñiguez-Lluhí JA; Lieberman AP
    J Clin Invest; 2015 Feb; 125(2):831-45. PubMed ID: 25607844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
    Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
    Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein modification by SUMO.
    Johnson ES
    Annu Rev Biochem; 2004; 73():355-82. PubMed ID: 15189146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell biological approaches to investigate polyglutamine-expanded AR metabolism.
    Cooper LJ; Merry DE
    Methods Mol Biol; 2013; 1017():241-53. PubMed ID: 23719921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human expanded polyglutamine androgen receptor mutants in neurodegeneration as a novel ligand target.
    Furutani T; Takeyama K; Tanabe M; Koutoku H; Ito S; Taniguchi N; Suzuki E; Kudoh M; Shibasaki M; Shikama H; Kato S
    J Pharmacol Exp Ther; 2005 Nov; 315(2):545-52. PubMed ID: 16079302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone.
    Stenoien DL; Cummings CJ; Adams HP; Mancini MG; Patel K; DeMartino GN; Marcelli M; Weigel NL; Mancini MA
    Hum Mol Genet; 1999 May; 8(5):731-41. PubMed ID: 10196362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse.
    Tokui K; Adachi H; Waza M; Katsuno M; Minamiyama M; Doi H; Tanaka K; Hamazaki J; Murata S; Tanaka F; Sobue G
    Hum Mol Genet; 2009 Mar; 18(5):898-910. PubMed ID: 19066230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
    Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
    Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy.
    Todd TW; Kokubu H; Miranda HC; Cortes CJ; La Spada AR; Lim J
    Elife; 2015 Aug; 4():e08493. PubMed ID: 26308581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SUMO on the road to neurodegeneration.
    Dorval V; Fraser PE
    Biochim Biophys Acta; 2007 Jun; 1773(6):694-706. PubMed ID: 17475350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.
    Kaytor MD; Wilkinson KD; Warren ST
    J Neurochem; 2004 May; 89(4):962-73. PubMed ID: 15140195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors.
    Iida M; Katsuno M; Nakatsuji H; Adachi H; Kondo N; Miyazaki Y; Tohnai G; Ikenaka K; Watanabe H; Yamamoto M; Kishida K; Sobue G
    Hum Mol Genet; 2015 Jan; 24(2):314-29. PubMed ID: 25168383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular pathogenesis of motor neuron diseases].
    Sobue G
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel polyglutamine-expanded aggregation species in spinal and bulbar muscular atrophy.
    Berger TR; Montie HL; Jain P; Legleiter J; Merry DE
    Brain Res; 2015 Dec; 1628(Pt B):254-264. PubMed ID: 26453288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.